Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · IEX Real-Time Price · USD
43.99
+1.23 (2.88%)
At close: Jul 26, 2024, 4:00 PM
44.87
+0.88 (2.00%)
After-hours: Jul 26, 2024, 4:57 PM EDT
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $2.28 billion as of July 26, 2024. Its market cap has increased by 331.34% in one year.
Market Cap
2.28B
Enterprise Value
1.65B
1-Year Change
331.34%
Ranking
Category
Stock Price
$43.99
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $2.28B, an increase of 271.65%. That is a compound annual growth rate of 52.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 2.22B | 347.54% |
| Dec 29, 2023 | 495.40M | -9.71% |
| Dec 30, 2022 | 548.70M | -33.17% |
| Dec 31, 2021 | 821.00M | 33.77% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integra LifeSciences Holdings | 2.47B |
| Protagonist Therapeutics | 2.47B |
| Ardent Health Partners | 2.43B |
| UFP Technologies | 2.43B |
| Privia Health Group | 2.39B |
| AMN Healthcare Services | 2.32B |
| Rocket Pharmaceuticals | 2.31B |
| Amneal Pharmaceuticals | 2.31B |